TALS insider filings

Talaris Therapeutics, Inc. — 50 most recent insider filings (SEC Forms 3/4/5) from EDGAR, normalized by FilingPulse. Latest filing: 2023-07-06. Screen TALS transaction legs live →

Insider transaction summary — last 90 days

No insider filings (Forms 3/4/5) for TALS between 2026-08-23 and 2026-11-21. The table below lists the most recent filings on record.

Recent insider filings — Talaris Therapeutics, Inc.

FiledFormInsiderReported transactionsSource
2023-07-064Requadt ScottTax withholding (F): 11,786 @ $3.08EDGAR
2023-07-064Fenton Mary Kay — Chief Financial OfficerTax withholding (F): 12,946 @ $3.08EDGAR
2023-06-144Ildstad Suzanne — DirectorSale (S): 16,870 @ $2.59 · Sale (S): 14,208 @ $2.56 · Sale (S): 12,942 @ $2.49 · Grant/award (A): 20,500 (derivative) @ $0EDGAR
2023-06-144Agarwala Sandip — DirectorGrant/award (A): 20,500 (derivative) @ $0EDGAR
2023-06-144MACKAY GEOFFREY — DirectorGrant/award (A): 20,500 (derivative) @ $0EDGAR
2023-06-144Shah Gaurav — DirectorGrant/award (A): 20,500 (derivative) @ $0EDGAR
2023-06-144Smith Karen L. — DirectorGrant/award (A): 20,500 (derivative) @ $0EDGAR
2023-06-144Srivastava Sapna — DirectorGrant/award (A): 20,500 (derivative) @ $0EDGAR
2023-06-144Nader Francois — DirectorGrant/award (A): 41,000 (derivative) @ $0EDGAR
2023-06-144MCDADE MARK — DirectorGrant/award (A): 20,500 (derivative) @ $0EDGAR
2023-06-094Ildstad Suzanne — DirectorSale (S): 75,001 @ $2.39 · Sale (S): 40,642 @ $2.48 · Sale (S): 25,419 @ $2.46EDGAR
2023-06-074Ildstad Suzanne — DirectorSale (S): 7,841 @ $2.52 · Sale (S): 25,549 @ $2.53EDGAR
2023-06-054Ildstad Suzanne — DirectorSale (S): 15,713 @ $2.56 · Sale (S): 15,818 @ $2.50EDGAR
2023-04-254Ildstad Suzanne — DirectorSale (S): 15,004 @ $2.35EDGAR
2023-04-214Ildstad Suzanne — DirectorSale (S): 21,753 @ $2.16 · Sale (S): 46,990 @ $2.33EDGAR
2023-04-194Ildstad Suzanne — DirectorSale (S): 99,771 @ $2.14 · Sale (S): 49,211 @ $2.15EDGAR
2023-04-074/AIldstad Suzanne — DirectorSale (S): 10,436 @ $2.06EDGAR
2023-04-074/AIldstad Suzanne — DirectorSale (S): 6,806 @ $2.06EDGAR
2023-04-074/AIldstad Suzanne — DirectorSale (S): 29 @ $2.05EDGAR
2023-04-074/AIldstad Suzanne — DirectorSale (S): 3,500 @ $2.05EDGAR
2023-04-074/AIldstad Suzanne — DirectorSale (S): 2,939 @ $2.06 · Sale (S): 3,612 @ $2.05EDGAR
2023-03-204Ildstad Suzanne — DirectorSale (S): 10,436 @ $2.06EDGAR
2023-03-074Ildstad Suzanne — DirectorSale (S): 6,806 @ $2.06EDGAR
2023-03-024Ildstad Suzanne — DirectorSale (S): 29 @ $2.05EDGAR
2023-02-234Ildstad Suzanne — DirectorSale (S): 3,500 @ $2.05EDGAR
2023-02-214Ildstad Suzanne — DirectorSale (S): 2,939 @ $2.06 · Sale (S): 3,612 @ $2.05EDGAR
2023-02-034Zdanowski Michael — Chief Technology OfficerGrant/award (A): 150,000 (derivative) @ $0 · Grant/award (A): 150,000 (derivative) @ $0EDGAR
2023-02-034Krieger Nancy — Chief Medical OfficerGrant/award (A): 120,000 (derivative) @ $0 · Grant/award (A): 120,000 (derivative) @ $0EDGAR
2023-02-034Requadt Scott — Chief Executive Officer, DirectorGrant/award (A): 4 @ $0.87 · Grant/award (A): 320,000 (derivative) @ $0 · Grant/award (A): 320,000 (derivative) @ $0EDGAR
2023-02-034Fenton Mary Kay — Chief Financial OfficerGrant/award (A): 150,000 (derivative) @ $0 · Grant/award (A): 150,000 (derivative) @ $0EDGAR
2022-09-134Zdanowski Michael — Chief Technology OfficerGrant/award (A): 120,000 @ $0EDGAR
2022-09-134Krieger Nancy — Chief Medical OfficerGrant/award (A): 80,000 @ $0EDGAR
2022-09-134Requadt Scott — Chief Executive Officer, DirectorGrant/award (A): 80,000 @ $0EDGAR
2022-09-134Fenton Mary Kay — Chief Financial OfficerGrant/award (A): 80,000 @ $0EDGAR
2022-09-134/ANader Francois — DirectorPurchase (P): 50,000 @ $3.52 · Purchase (P): 52,000 @ $3.62 · Other (J): 248,432 @ $0 · Other (J): 248,432 @ $0 · Purchase (P): 36,500 @ $3.72 · Other (J): 138,500 @ $0 · +1 moreEDGAR
2022-08-234Ildstad Suzanne — Chief Scientific OfficerSale (S): 525,000 @ $2.80EDGAR
2022-08-024Requadt Scott — Chief Executive Officer, DirectorPurchase (P): 39,382 @ $4.25EDGAR
2022-07-284Requadt Scott — Chief Executive Officer, DirectorPurchase (P): 5,528 @ $4.24 · Purchase (P): 3,090 @ $4.25EDGAR
2022-07-264Requadt Scott — Chief Executive Officer, DirectorPurchase (P): 9,444 @ $3.75EDGAR
2022-07-254Nader Francois — DirectorPurchase (P): 50,000 @ $3.52 · Purchase (P): 52,000 @ $3.62 · Other (J): 248,432 @ $0 · Other (J): 248,432 @ $0 · Purchase (P): 36,500 @ $3.72 · Other (J): 138,500 @ $0 · +1 moreEDGAR
2022-06-134Agarwala Sandip — Director, 10% ownerGrant/award (A): 14,501 (derivative) @ $0EDGAR
2022-06-134MACKAY GEOFFREY — DirectorGrant/award (A): 14,501 (derivative) @ $0EDGAR
2022-06-134Shah Gaurav — DirectorGrant/award (A): 14,501 (derivative) @ $0EDGAR
2022-06-134Smith Karen L. — DirectorGrant/award (A): 14,501 (derivative) @ $0EDGAR
2022-06-134Srivastava Sapna — DirectorGrant/award (A): 14,501 (derivative) @ $0EDGAR
2022-06-134Nader Francois — DirectorGrant/award (A): 14,501 (derivative) @ $0EDGAR
2022-06-134MCDADE MARK — DirectorGrant/award (A): 14,501 (derivative) @ $0EDGAR
2022-05-174Smith Karen L. — DirectorGrant/award (A): 29,002 (derivative) @ $0EDGAR
2022-02-024Requadt Scott — Chief Executive Officer, DirectorGrant/award (A): 1,470 @ $13 · Grant/award (A): 500,000 (derivative) @ $0EDGAR
2022-02-024Fenton Mary Kay — Chief Financial OfficerGrant/award (A): 1,000 @ $13 · Grant/award (A): 200,000 (derivative) @ $0EDGAR

Recent 8-K events — Talaris Therapeutics, Inc.

Items classified from EDGAR index headers. Browse recent 8-K filings market-wide, by item code →

FiledFormItems reportedSource
2025-10-288-K1.02 — Termination of a Material Definitive Agreement
2.01 — Completion of Acquisition or Disposition of Assets
3.01 — Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
3.03 — Material Modification to Rights of Security Holders
5.01 — Changes in Control of Registrant
5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
5.03 — Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
9.01 — Financial Statements and Exhibits
EDGAR
2025-09-128-K5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain OfficersEDGAR
2025-09-098-K1.01 — Entry into a Material Definitive Agreement
7.01 — Regulation FD Disclosure
9.01 — Financial Statements and Exhibits
EDGAR
2025-08-138-K2.02 — Results of Operations and Financial Condition
9.01 — Financial Statements and Exhibits
EDGAR
2025-06-098-K7.01 — Regulation FD DisclosureEDGAR
2025-06-068-K5.07 — Submission of Matters to a Vote of Security HoldersEDGAR
2025-05-208-K7.01 — Regulation FD Disclosure
8.01 — Other Events
EDGAR
2025-05-028-K2.02 — Results of Operations and Financial Condition
9.01 — Financial Statements and Exhibits
EDGAR
2025-03-138-K2.02 — Results of Operations and Financial Condition
9.01 — Financial Statements and Exhibits
EDGAR
2024-12-108-K7.01 — Regulation FD Disclosure
8.01 — Other Events
EDGAR
Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?ticker=TALS returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new ones to you in seconds. Get a free API key → · API docs